These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 28034681

  • 1. Risks of second malignancies after breast cancer treatment: Long-term results.
    Bazire L, De Rycke Y, Asselain B, Fourquet A, Kirova YM.
    Cancer Radiother; 2017 Feb; 21(1):10-15. PubMed ID: 28034681
    [Abstract] [Full Text] [Related]

  • 2. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation?
    Hamilton SN, Tyldesley S, Li D, Olson R, McBride M.
    Int J Radiat Oncol Biol Phys; 2015 Apr 01; 91(5):977-85. PubMed ID: 25832690
    [Abstract] [Full Text] [Related]

  • 3. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment.
    Rubino C, Shamsaldin A, Lê MG, Labbé M, Guinebretière JM, Chavaudra J, de Vathaire F.
    Breast Cancer Res Treat; 2005 Feb 01; 89(3):277-88. PubMed ID: 15754127
    [Abstract] [Full Text] [Related]

  • 4. Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients.
    Grantzau T, Overgaard J.
    Radiother Oncol; 2016 Dec 01; 121(3):402-413. PubMed ID: 27639892
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increased risk of second cancers following breast cancer: role of the initial treatment.
    Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Lê MG.
    Breast Cancer Res Treat; 2000 Jun 01; 61(3):183-95. PubMed ID: 10965995
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
    Kleinerman RA, Tucker MA, Abramson DH, Seddon JM, Tarone RE, Fraumeni JF.
    J Natl Cancer Inst; 2007 Jan 03; 99(1):24-31. PubMed ID: 17202110
    [Abstract] [Full Text] [Related]

  • 9. Long-term risk of sarcoma following radiation treatment for breast cancer.
    Taghian A, de Vathaire F, Terrier P, Le M, Auquier A, Mouriesse H, Grimaud E, Sarrazin D, Tubiana M.
    Int J Radiat Oncol Biol Phys; 1991 Jul 03; 21(2):361-7. PubMed ID: 1648044
    [Abstract] [Full Text] [Related]

  • 10. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
    Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, Van Buren T, Baldini EH, Harris JR.
    Int J Radiat Oncol Biol Phys; 2002 Feb 01; 52(2):406-14. PubMed ID: 11872286
    [Abstract] [Full Text] [Related]

  • 11. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M, Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW, Roesink J, Raemaekers JM, de Boer JP, Zijlstra JM, van Imhoff GW, Petersen EJ, Poortmans PM, Beijert M, Lybeert ML, Mulder I, Visser O, Louwman MW, Krul IM, Lugtenburg PJ, van Leeuwen FE.
    N Engl J Med; 2015 Dec 24; 373(26):2499-511. PubMed ID: 26699166
    [Abstract] [Full Text] [Related]

  • 12. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan.
    Matsuyama Y, Tominaga T, Nomura Y, Koyama H, Kimura M, Sano M, Miura S, Takashima S, Mitsuyama S, Ueo H, Ohashi Y.
    Ann Oncol; 2000 Dec 24; 11(12):1537-43. PubMed ID: 11205460
    [Abstract] [Full Text] [Related]

  • 13. Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review.
    Kirova YM, Gambotti L, De Rycke Y, Vilcoq JR, Asselain B, Fourquet A.
    Int J Radiat Oncol Biol Phys; 2007 Jun 01; 68(2):359-63. PubMed ID: 17379448
    [Abstract] [Full Text] [Related]

  • 14. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Pukkala E, Lynch CF, Pee D, Smith SA, Van't Veer MB, Joensuu T, Storm H, Stovall M, Boice JD, Gilbert E, Gail MH.
    J Natl Cancer Inst; 2005 Oct 05; 97(19):1428-37. PubMed ID: 16204692
    [Abstract] [Full Text] [Related]

  • 15. Breast cancer after treatment of Hodgkin's disease.
    Hancock SL, Tucker MA, Hoppe RT.
    J Natl Cancer Inst; 1993 Jan 06; 85(1):25-31. PubMed ID: 8416252
    [Abstract] [Full Text] [Related]

  • 16. Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma.
    Bachaud JM, Berthier F, Soulié M, Malavaud B, Plante P, Rischmann P, Chevreau C, Daly-Schveitzer N, Grosclaude P.
    Radiother Oncol; 1999 Feb 06; 50(2):191-7. PubMed ID: 10368043
    [Abstract] [Full Text] [Related]

  • 17. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
    van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, van Heerde P, Somers R.
    J Clin Oncol; 1994 Feb 06; 12(2):312-25. PubMed ID: 8113838
    [Abstract] [Full Text] [Related]

  • 18. Late effects of adjuvant therapy for breast cancer.
    Shapiro CL, Recht A.
    J Natl Cancer Inst Monogr; 1994 Feb 06; (16):101-12. PubMed ID: 7999452
    [No Abstract] [Full Text] [Related]

  • 19. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
    Kuttesch JF, Wexler LH, Marcus RB, Fairclough D, Weaver-McClure L, White M, Mao L, Delaney TF, Pratt CB, Horowitz ME, Kun LE.
    J Clin Oncol; 1996 Oct 06; 14(10):2818-25. PubMed ID: 8874344
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.